Business Context and Reporting Period
TASER International, Inc. (now Axon Enterprise, Inc.) filed an unaudited Form 10-Q for the three months ended March 31, 2014, compared with the three months ended March 31, 2013. The company developed and sold conducted electrical weapons, accessories, AXON cameras, and EVIDENCE.com digital evidence-management software and services. Reportable segments were TASER Weapons and EVIDENCE.com & Video.
Financial Highlights
| Metric | Q1 2014 | Q1 2013 | Change |
|---|---|---|---|
| Net sales | $36.2 million | $30.4 million | 18.9% increase |
| Gross margin | $22.2 million; 61.4% | $18.5 million; 60.6% | 20.4% increase; 80 bps expansion |
| Income from operations | $4.9 million; 13.4% | $5.3 million; 17.3% | 7.6% decrease; 390 bps contraction |
| Net income | $3.4 million; 9.4% | $3.3 million; 10.8% | 2.8% increase |
| Diluted EPS | $0.06 | $0.06 | No reported change |
| Net cash from operations | $4.3 million | $4.5 million | Decrease of $0.2 million |
- TASER Weapons revenue increased 16.0% to $32.5 million. EVIDENCE.com & Video revenue increased 52.6% to $3.7 million.
- International sales rose to $10.6 million, or 29.3% of revenue, from $3.1 million, or 10.3%, in the prior-year quarter.
- Sales growth was led by the X26P Smart Weapon, which generated $7.9 million, and a $2.5 million XREP international order. X26 and X2 revenue declined.
- EVIDENCE.com and AXON flex bookings increased to $5.9 million from $1.4 million. Future bookings may be subject to government appropriations or cancellation clauses.
- SG&A increased 22.9% to $13.7 million, and research and development increased 79.1% to $3.6 million, reflecting investment in video products, software, sales capacity, marketing, and administrative infrastructure.
- Video segment operating loss widened to $4.6 million from $1.5 million, while TASER Weapons operating income increased to $9.5 million from $6.7 million.
- Cash and cash equivalents were $45.1 million at March 31, 2014, compared with $42.3 million at December 31, 2013. Total cash, cash equivalents, and investments were $77.5 million.
- Total assets were $164.8 million and total liabilities were $41.0 million at March 31, 2014. Capital lease obligations totaled approximately $0.1 million; there were no borrowings under the revolving credit facility.
- The $10.0 million revolving credit facility had $9.4 million available after letters of credit. The company was in compliance with its financial covenants.
Material Changes Versus the Prior Comparable Period
- Revenue growth accelerated through adoption of the X26P, increased international sales, a large XREP order, and growth in AXON and EVIDENCE.com products and services.
- Overall gross margin improved modestly, but EVIDENCE.com & Video gross margin declined to 17.5% from 27.4% because of product costs, deferred recognition of separately priced SaaS services, and low-margin AXON camera pricing intended to build market adoption.
- Operating margin declined despite higher gross profit because SG&A and R&D grew faster than revenue. The first quarter included approximately $0.7 million of net expense related to the Turner litigation settlement.
- Operating cash flow was broadly stable, while investing cash flow changed to a $12.3 million use from a $1.2 million source, primarily because the company purchased investments. Financing cash flow changed to a $10.9 million source, principally from employee stock-option exercises, versus a $3.3 million use in the prior-year quarter that included share repurchases.
- Deferred revenue increased to $21.5 million from $20.2 million at December 31, 2013, primarily relating to warranties and EVIDENCE.com services.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- Management expected SG&A and R&D spending to continue increasing during 2014 as it invested in EVIDENCE.com, video products, international expansion, and support functions.
- Management expected near-term EVIDENCE.com & Video gross margins to remain lower because SaaS revenue is deferred and AXON cameras were being sold at low gross margins to accelerate adoption.
- The estimated 2014 effective tax rate before discrete adjustments was approximately 39.1%; the reported first-quarter effective rate was 30.6%.
- The company believed operating cash flow, cash balances, and available credit were sufficient to fund 2014 operations and strategic initiatives, but noted that future cash generation and credit availability were not assured.
- The company faced 18 active product-liability lawsuits and one matter on appeal involving alleged wrongful death or personal injury related to TASER devices. The Turner litigation was settled for $3.4 million; insurance covered $2.7 million and the company’s net responsibility was approximately $0.7 million. The settlement exhausted the company’s 2008 general and excess insurance policies.
- A separate commercial dispute produced a $3.3 million jury verdict against the company. Judgment had not been entered as of filing, and the company intended to appeal; additional attorneys’ fees could result in further expense.
- The company carried approximately $3.1 million of unrecognized tax benefits. Recognition would favorably affect the effective tax rate, but the tax positions remained subject to examination.
- Key disclosed risks included dependence on X26, X26P, and X2 sales; acceptance of the EVIDENCE.com subscription model; product defects; data-security breaches and service outages; government budget and appropriation constraints; international and foreign-exchange exposure; litigation and adverse publicity; intellectual-property claims; regulation; supply-chain constraints; and employee retention.
Most Important Facts for Investors to Verify
- Whether X26P adoption and international orders were sustainable or reflected unusually large, intermittent purchases.
- Progress toward improving EVIDENCE.com & Video margins and reducing the segment’s operating loss.
- The conversion of $5.9 million of video-related bookings into invoiced and recognized revenue, including exposure to appropriation or cancellation clauses.
- Trends in product-liability claims, insurance coverage, legal reserves, and the commercial litigation verdict and appeal.
- Whether rising SG&A and R&D investment produces the expected growth in video and SaaS revenue.
- Utilization of deferred tax assets and the ultimate resolution of approximately $3.1 million of unrecognized tax benefits.
- Cash-flow quality, investment concentration, warranty reserves, deferred revenue recognition, and compliance with revolving-credit covenants.